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a Second Department of Obstetrics and Gynecology, b Institute of Human Physiology and Clinical Experimental Research, c Department of
Pathophysiology, Semmelweis University Budapest, and d Department of Cardiology, Bajcsy-Zsilinszky Hospital, Budapest, HungaryObjective: To investigate the vascular dysfunction caused by insulin resistance in polycystic ovary syndrome (PCOS) and the effectiveness of vitamin D
in an animal model.
Design: Controlled experimental animal study.
Setting: Animal laboratory at a university research institute.
Animal(s): Thirty female Wistar rats.
Intervention(s): Rats were divided into groups at age 21–28 weeks. Twenty of themwere subjected to dihydrotestosterone (DHT) treatment (83 mg/d); ten
of them also received parallel vitamin D treatment (120 ng/100 g/wk). Oral glucose tolerance tests with insulin level measurements were performed. Gra-
cilis arterioles were tested for their contractility as well as their nitric oxide (NO)–dependent and insulin-induced dilation using pressure arteriography.
Main Outcome Measure(s): Several physiologic parameters, glucose metabolism, and pressure arteriography.
Result(s): DHT treatment increased the passive diameter of resistance arterioles, lowered norepinephrine-induced contraction (30.1  4.7% vs. 8.7 
3.6%) and reduced acetylcholine-induced (122.0  2.9% vs. 48.0  1.4%) and insulin-induced (at 30 mU/mL: 21.7  5.3 vs. 9.8  5.6%) dilation.
Vitamin D treatment restored insulin relaxation and norepinephrine-induced contractility; in contrast, it failed to alter NO-dependent relaxation.
Conclusion(s): In DHT-treated rats, in addition to metabolically proven insulin resistance, decreased insulin-induced vasorelaxation was observed and
was improved by vitamin D treatment without affecting NO-dependent relaxation. The reduction in insulin-induced dilation of arterioles is an important
as yet undescribed pathway of vascular damage in PCOS and might explain the clinical effectiveness of vitamin D treatment. (Fertil Steril 2012;-:
-–-. 2012 by American Society for Reproductive Medicine.)
Key Words: PCOS, vascular insulin resistance, vitamin D, arterioleolycystic ovary syndrome (PCOS) (1, 2). The mechanisms underlying this these therapies are largely knownP affects 5%–8% of fertile women.It is already well known that in-
creased insulin resistance and altered
metabolic status occur in these patients.
PCOS also alters cardiovascular func-
tion through various mechanisms (1, 2).
In 2000, Lakhani and Hardiman
suggested that in women with PCOS,
the internal carotid artery pulsatility
index is decreased and cardiovascular
risk increased (3, 4). Since then, it has
been shown that women with PCOS
have an early increased prevalence of
atherosclerosis, metabolic syndrome,
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approaches are still subjects of
investigation. Human studies have
shown microvascular dysfunction in
PCOS, as indicated by reductions in
acetylcholine (Ach)–dependent vasodil-
ation. This impaired response to Ach is
similar to that which has been observed
in noninsulin-dependent diabetes melli-
tus and is supposed to relate to the
metabolic alterations, particularly the
insulin resistance, of PCOS (5).
In PCOS, glucose metabolism can
be improved with insulin sensitizers,
and the positive vascular effects of2011; accepted November 14, 2011.
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Medicine, Published by Elsevier Inc.(6, 7). Vitamin D may be also used as
adjuvant therapy in women with
PCOS (8). The positive effects of
vitamin D administration on glucose
metabolism (9, 10) and the reduction
of cardiovascular complications (11,
12) are known, but vitamin D is not
yet commonly used in PCOS therapy.
To understand the pathologic
mechanisms of PCOS and make timely
therapeutic interventions, it is neces-
sary to concentrate on earlier stages
of the disease. Manneras et al. devel-
oped a model for human PCOS by
giving dihydrotestosterone (DHT) to
adolescent female rats. After 90 days,
this treatment altered ovarian mor-
phology and vital parameters; early
impairment of glucose metabolism
was also found. The authors suggested
that the DHT model is suitable for
studies of the metabolic and ovarian
features of the syndrome (13, 14).
The aim of the present study was to
determine the early effects of DHT treat-
ment on glucose metabolism and arteri-
olar function before the appearance of1
ORIGINAL ARTICLE: REPRODUCTIVE BIOLOGYhypertension. We also examined the potentially beneﬁcial ef-
fects of vitamin D.
We had previously studied the vascular alterations that
occur after 10 weeks of treatment of adolescent female rats
with DHT, before the appearance of hypertension. In the pres-
ent study, we gave protective doses of vitamin D to a group of
hyperandrogenic female (HAF) rats. In an earlier study, a sim-
ilar chronic vitamin D treatment regimen prevented cardiac
failure and left ventricular hypertrophy in infant heart
failure-prone SHR rats (12).MATERIALS AND METHODS
Chemicals
The normal Krebs-Ringer (nKR) solution that was used in the
in vitro studies consisted of (in mmol/L) NaCl 119, KCl 4.7,
NaH2PO4 1.2, MgSO4 1.17, NaHCO3 24, CaCl2 2.5, glucose
5.5, and EDTA 0.034. A Ca2þ-free Krebs solution containing
(in mmol/L) NaCl 92, KCl 4.7, NaH2PO4 1.18, MgCl2 20,
MgSO4 1.17, NaHCO3 24, glucose 5.5, EGTA 2, and EDTA
0.025 was used to relax smooth muscle. The temperature of
the solution was kept at 37C, and it was bubbled with 5%
CO2, 20% O2, and 75% N2, which stabilized the pH at 7.4.
Norepinephrine (NE), Ach, and L-NG-nitroarginine methyl
ester (L-NAME) was obtained from Sigma-Aldrich. Human re-
combinant insulin (Actrapid Penﬁll, 100 IU/mL) was obtained
fromNovo Nordisk. Drugs were freshly prepared on the day of
the experiment in an nKR solution.Animals
The protocol for inducing experimental polycystic ovary
syndrome has been previously described by Manneras et al.
(13). Continuous-release pellets containing 7.5 mg DHT
(Innovative Research of America) were applied for 70 days.
Releases of 83 mg/d for 90 days are guaranteed by the manu-
facturer. Under anesthesia (Nembutal, 45 mg/kg intraperito-
neally; Phylaxia-Sanoﬁ) in sterile conditions, 20 sexually
adolescent (21–28 days old) female Wistar rats, which were
provided by the Animal Facility of the Semmelweis University
in agreement with Charles River and weighed 100–140 g at
the beginning of the study, received subcutaneous pellets
containing 7.5 mg DHT implanted under the back skin (DHT
group). Ten animals underwent sham operations (control
group). After the surgical intervention, a mixture of 20 mg
amoxicillin and 4 mg clavulanic acid (Augmentin; Glaxo
Smith Kline) in 0.2 mL saline solution was administered
intramuscularly to prevent infection.
Ten of the DHT-treated animals received weekly doses of
120 ng/100 g vitamin D (12) applied in injections of 1,25(OH)2
vitamin D3 (12) (Injectable Calcijex, 2 mg/mL; Abbott Labora-
tories; DHTþD3 group). The remaining 20 animals received
vehicle. No medical or surgical complications were observed.
Conventional rat food and tap water were provided ad libi-
tum. After 8 weeks of treatment, an oral glucose tolerance
test (OGTT) was performed under short ether narcosis. Blood
glucose and plasma insulin were measured after overnight
fasting and 120 minutes after an oral glucose load of
0.3 g/100 g body weight given through a gauge (15, 16).2Blood glucose was measured by Decont Personal Akucheck
(77 Electronics). For the insulin measurements, a Rat/Mouse
Insulin ELISA was used (Millipore). Serum fructose-amine
was determined by Roche 930010 test. This study conformed
to the Principles of Laboratory Animal Care, National
Institutes of Health publication no. 85-23 (revised 1985)
and the Euroconform Hungarian Law on Animal Care
(XXVIII/1998) and was approved by the institutional Animal
Care Commission (Institutional Review Board approval: 22.1/
2960/003/2009).Pressure Arteriography of Gracilis Arterioles
After 10 weeks of treatment, animals were reanesthetized
(Nembutal 45 mg/kg intraperitoneally). Their blood pressure
was measured directly by cannulation of the carotid artery.
After opening the iliofemoral region, the gracilis arteriole
supplying the gracilis muscle, which measures 150 mm in
diameter in vivo, was removed and placed into a vessel cham-
ber ﬁlled with nKR solution. The arteriole was cannulated at
both ends with plastic microcannulas and extended to its
in vivo length. Both cannulas were connected to pressure-
servo pumps (Living Systems), and the arterioles were pres-
surized in a no-ﬂow condition to 50 mm Hg intraluminal
pressure.
The outer and the inner diameters of the arteries were
measured by videomicroscopic microangiometry. In this
setup, the glass-bottomed tissue bath was positioned in the
light path of an inverse Leica microscope. A magniﬁed picture
of the vessel was formed with the aid of a video camera (Leica
DFC320) and Leica QWin software. The digitized pictures were
saved and off-line measurements of the inner and outer
diameters were made using the Leica QWin image analyzing
software.
Gracilis arterioles were allowed to equilibrate for 30 min-
utes at 50 mm Hg intraluminal pressure in an oxygenized
nKR solution. The steady-state diameter was measured. The
diameter was also measured during norepinephrine (NE) con-
traction after a 10-minute incubation period with 106 mol/L
NE. After recording the NE-diameter at 50 mm Hg, dose-
diameter curves were recorded in the presence of 30, 60,
120, 240, and 600 mU/mL of insulin, leaving an equilibration
period of 8–10 minutes for each dose, which allowed a stable
diameter to be reached and measured. After rinsing, NE was
added to the organ bath in the same dose as previously
described. After 10 minutes of incubation at 50 mm Hg,
106 mol/L Ach was added to the organ bath, and after
another 20 minutes the outer and inner diameters were mea-
sured. Then, 105 mol/L L-NAME was administered, and after
equilibrium was reached the diameters were measured again;
at this step, equilibration required 25–30 minutes at 50 mm
Hg. Finally, the passive diameter was obtained after 20 min-
utes incubation in a Ca2þ-free Krebs solution. Segments were
incubated for 20 minutes, and then the steady-state fully re-
laxed diameter was measured. The effect of insulin þ NE was
compared with the NE-induced contraction without insulin
and with full relaxation. Calibrations were made with an
etalon micrometer (Wild). Insulin-induced relaxations of
precontracted segments were normalized to the NE-inducedVOL.- NO.- /- 2012
Fertility and Sterility®precontraction without insulin: (RIns RNE)/RNE. The insulin-
induced relaxation of NE-precontracted segments was nor-
malized to the relaxation induced in the same segments by
the Ca-free free medium: (RIns RNE)/(RCafree RNE). In a sim-
ilar manner, the Ach-relaxation and the effect of L-NAME
were compared with NE-precontraction. Thus, all parameters
are independent of absolute vessel diameter.Histology and Histometry
Ovaries were removed, ﬁxed with formaldehyde, stained with
hematoxylin-eosin, and histologically examined.We detected
polycystic morphology in the DHT-treated groups and normal
ovaries in the control groups, as published earlier inManneras
and Yanes (13, 14). Morphometric measurements were made
using the Pannoramic Viewer software (3D Histech).Statistics
A repeated-measures analysis of variance (ANOVA) was used
for the statistical analysis of the cumulative concentration-
diameter curves. A one-way ANOVA was applied to discrete
parameters, e.g., body weights. Tukey test was used as
a post hoc test. P< .05 was uniformly accepted as the




The mean arterial pressures were: control, 122  3 mm Hg;
DHT, 123  6 mm Hg; and DHTþD3, 123  4 mm Hg. The
mean body weight in the two DHT-treated groups was signif-
icantly higher than in the control group. However, the two
treatment groups did not differ from each other at the end
of the experiment (control, 298  8 g; DHT, 354  16 g;
DHTþD3, 353  9 g).Glucose Metabolism
The fasting and 120-minute postload blood glucose and insu-
lin values are presented in Table 1. The blood glucose levels
and the fasting insulin levels were not signiﬁcantly differentTABLE 1
Results of oral glucose tolerance test.
Control (n[ 10)
Blood sugar 00 5.31  0.15 mmol
Blood sugar 1200 6.11  0.11 mmol
Insulin 00 0.42  0.02 ng/mL
Insulin 1200 0.71  0.14 ng/mL
Glycated protein (fructoseamine) 157  3 mmol/L
Ach-induced relaxation (Ri Ach  Ri Ne)/Ri Ne 1.22  0.29
L-NAME–induced contraction (Ri Ach  Ri
LNAME)/Ri Ach
0.21  0.10
Note: The 120-minute postload insulin level in the DHT group was signiﬁcantly higher than in the
glucose tolerance test (zP< .001). There were no signiﬁcant differences in other parameters: blood su
greater in the control than the other two groups (*,yP< .05). The L-NAME–induced contraction was
DHT ¼ dihydrotestosterone.
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ences were found among the groups for the 120-minute post-
load insulin values. DHT-treated animals had higher plasma
insulin levels than the control animals, and this difference
was eliminated by the D3 vitamin treatment. Values for
glycated proteins also did not differ (Table 1).Pressure Arteriography
The relaxed inner radii of the gracilis arterioles were signiﬁ-
cantly larger in the DHT-only compared with the other two
groups (DHT, 96  3 mm; control, 84  6 mm; DHTþD3, 83
 5 mm; both P< .05). NE-contractions were reduced in
DHT-treated animals, and this was mostly restored after
parallel D3 vitamin treatment (Fig. 1; P< .05 for both control
vs. DHT and DHT vs. DHTþD3). Ach-dilations were severely
diminished in the DHT-treated female animals (Table 1).
Vitamin D3 treatment produced only a nonsigniﬁcant trend
toward restoring relaxation. In the presence of Ach, the inhi-
bition of NO synthesis with L-NAME caused contraction,
which was missing in the DHT-treated groups, thus proving
that vascular NO synthesis was altered in these vessels
(Table 1).
Insulin administered to NE-precontracted gracilis arteri-
ole segments induced concentration-dependent relaxation
in the control animals (Fig. 2). This relaxing effect was
much reduced in the DHT-treated group (P< .001). The ad-
ministration of vitamin D3 partially restored the insulin-
induced relaxation (P< .001).
Another signiﬁcant effect of vitamin D3 treatment was
revealed when we compared the NE-induced contractions of
segments before and after in vitro treatment with elevating
concentrations of insulin. Typically, NE-induced contractions
were more profound after insulin treatment (Fig. 3). This dif-
ference was reduced in vitamin D3-treated animals (P< .05).DISCUSSION
As a model of human polycystic ovary syndrome, 10 weeks of
DHT treatment starting during adolescence in female rats (13,
14) induced signiﬁcant arteriole alterations in our studies. We
observed an increase in vascular diameter, a reduction of theDHT (n[ 10) DHTD vitamin D (n[ 10)
/L 5.35  0.24 mmol/L 5.18  0.27 mmol/L
/L 6.36  0.2 mmol/L 7.09  0.13 mmol/L
0.42  0.03 ng/mL 0.45  0.04 ng/mL
1.42  0.33 ng/mL* 0.48  0.07 ng/mLz
151  4 mmol/L 156  4 mmol/L
0.48  0.14* 0.70  0.10y
0.03  0.05* 0.02  0.02
control group (*P< .01). Vitamin D treatment normalized the insulin response during the oral
gar 00 , 1200 , insulin 00 , and glycated protein levels. The Ach-induced relaxationwas signiﬁcantly
signiﬁcantly lower in the DHT group than in the control group (P< .05). n ¼ 10 in each group.
3
FIGURE 1
Contraction of gracilis arterioles. The bars show the ratio of
norepinephrine (Ne)–induced contraction (inner radii) compared
with the diameter measured in normal Krebs-Ringer solution (nKR;
%) at 50 mm Hg. The values are expressed as mean  SEM.
Dihydrotestosterone (DHT) signiﬁcantly differs from control
(*P<.01) and DHTþD3 (zP<.05).
Sara. Vascular insulin resistance in PCOS. Fertil Steril 2012.
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dilation. Insulin-induced relaxation was also diminished.
Chronic vitamin D3 treatment restored vascular diameter
and improved NE-induced contraction. In animals treated
with vitamin D3, the insulin-evoked relaxation returned to
the control level. Although increased insulin resistance inFIGURE 2
(A) Insulin-induced vascular tone (T insulin) as a function of norepinephrin
values on the abscissa show the inner radii ratios of insulin-induced and N
concentrations. Values are expressed as mean  SEM. *The dihydrotesto
DHTþD3 group differs signiﬁcantly from the DHT group (P<.0001). (B) T
three experimental groups. The values on the abscissa show the inner ra
with the NE-induced tone at 50 mm Hg. The x axis shows different conce
*The DHT group is signiﬁcantly different from the control group (P<.01). zTh
Sara. Vascular insulin resistance in PCOS. Fertil Steril 2012.
4human PCOS disease and in DHT-treated female animals
has been described previously, the alteration of the well
known vasodilator activity of insulin was not studied. In ad-
dition, the artery resistance effects of vitamin D3 treatment,
which improves both the alterations associated with PCOS
(Figs. 1 and 2) and insulin resistance (Table 1), had not yet
been investigated.
The experimental model used in the present study has
been proven to be an adequate rat PCOS model (13, 14). It
has been shown that an 8–12-week DHT treatment identical
to the one that we used induces PCOS and signiﬁcantly, ap-
proximately threefold, increases androgen levels in female
rats (13). Yanes has detected several metabolic abnormalities
(14). Despite normal E2 levels, DHT-treated animals exhibited
estrus cycle dysfunction. A signiﬁcant increase in body
weight was detected, which was also noted in the present
study. This difference in body weight may be a consequence
of an androgen-dependent increase in adiponectin receptor
expression and low serum levels of adiponectin (17, 18).
The effect on body weight was not inﬂuenced by vitamin
D3 treatment. Based on elevated blood glucose and insulin
levels, Yanes hypothesized that insulin resistance occurs in
hyperandrogenic female rats (14). This hypothesis is
supported by our measurements, because the OGTT did not
show glucose metabolism abnormalities, and no difference
was found in the fasting blood insulin levels, but
a threefold increase was noted in the 2-hour post–glucose
load value compared with the control animals. Considering
these facts, our experimental model was suitable for studying
early initial abnormalities and vascular damage. Although
type 2 diabetes mellitus had not yet developed, the 2-houre (NE) tone in gracilis arterioles in the three experimental groups. The
E-induced tone at 50 mm Hg. The x axis shows the different insulin
sterone (DHT) group differs signiﬁcantly from control (P<.0001). zThe
insulin as a function of Ca-free relaxation in gracilis arterioles in the
dii ratios of insulin-induced tone in the Ca2þ-free solution compared
ntrations of insulin levels. The values are expressed as mean  SEM.
e DHTþD3 group is signiﬁcantly different from the DHT group (P<.01).
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FIGURE 3
The difference between the ﬁrst and the second norepinephrine (Ne)–
induced contractions after insulin administration compared with the
maximal relaxation in Ca-free solution. The values are expressed as
mean  SEM. yThe dihydrotestosterone (DHT)þD3 group is
signiﬁcantly different from the control (P<.05). zThe DHTþD3
group is signiﬁcantly different from the DHT group (P<.05).
Sara. Vascular insulin resistance in PCOS. Fertil Steril 2012.
Fertility and Sterility®insulin value of the OGTT showed insulin resistance. This
early glucose metabolism abnormality was fully prevented
by vitamin D3 treatment.
The DHT treatment applied by Yanes et al. resulted in hy-
pertension when administered for a longer period of time
(90 days) (14). During our 70-day treatment, no signiﬁcant
differences were found among the blood pressure values of
the experimental groups. This result means that the changes
detected are directly attributable to either hyperandrogenism
or hyperinsulinemia/insulin resistance and are independent
of blood pressure. During the 90-day treatment, Yanes et al.
detected an increase in spontaneous proteinuria, morphologic
renal damage, and elevated transforming growth factor a,
leptin, and cholesterol levels, indicating increased oxidative
stress and increased NADPH oxidase 4 expression (14). These
metabolic abnormalities may inﬂuence the pharmacologic
response of the arteries.
The direct vascular effects of chronic hyperandrogenism
must also be considered. The predominant direct vascular
effect of androgens is vasorelaxation. Both DHT, dependent
on dose, and T block the L-type voltage-operated calcium
channels, whereas high concentrations of T induce direct vas-
orelaxation because of its Ca-antagonist effect and increased
cyclic adenosine monophosphate production in the rat aorta
(19). A similar but slightly weaker Ca-dependent vasorelaxant
effect of E2 was noted in rat aorta after phenylephrine precon-
traction (20). Chronic low-dose T administration improved
the risk of myocardial ischemia (21), lipid proﬁle, and insulin
resistance because of its direct vasoactive and metabolic
effects (22). Despite progressive atherosclerosis, chronic T
treatment enhanced Ach-dependent, endothelium-dependent
relaxation in ovariectomized female monkeys, although it did
not inﬂuence direct smooth muscle-dependent relaxation
elicited by sodium nitroprusside (23). Yanes et al. foundVOL.- NO.- /- 2012elevated intrarenal angiotensinogen levels and angiotensin
I–converting enzyme expression as well as decreased
angiotensin II receptor 1 expression in HAF rats (14). Human
experiments have shownmicrovascular dysfunction in PCOS,
as indicated by the inhibition of Ach-dependent vasodilation
(5). Endothelial dysfunction and damage has been shown to
be enhanced by increased inﬂammatory and soluble activa-
tion markers (24). Paraoxonase-1 and ﬂow-mediated dilation
have been shown to be useful predictors of endothelial dys-
function (25). The effects of chronic androgen treatment are
currently a subject of debate. On the one hand, these effects
are species speciﬁc, but on the other hand, distinct effects
of the different androgenic compounds probably also exist.
The pharmacologic effects on vessel reactivity of some
products used in PCOS treatment are still under investigation.
Meyer noted the importance of accounting for not only the
hyperandrogenic symptoms but also the changes in glucose
metabolism, stiffness, and pulse-wave velocity during PCOS
treatment; treatment with metformin rather than high-dose
oral contraceptives has been suggested (26, 27). Agarwal
et al. (6) has shown that metformin decreases the arterial
stiffness, aortic and brachial pulse-wave velocity, and aortic
augmentation index and improves endothelium-dependent
and independent vascular responses (20, 28, 29). Increased
ﬂow-mediated vasodilation has been considered during
insulin-sensitizing treatment with metformin or pioglitazone
in PCOS women (7). The treatment protocols used in PCOS
often modify the cardiovascular risk of patients (6, 26).
High-dose oral contraceptives usually increase the risk; met-
formin has been proven to decrease the risk, and low-dose
oral contraceptives probably have no effect (6, 26).
In our experiments, vitamin D3 treatment signiﬁcantly
decreased the vascular insulin resistance caused by DHT. Dur-
ing NE-induced precontraction, DHT treatment decreased
insulin-dependent relaxation, thus producing vascular insulin
resistance. However, similar relaxation was observed in the
control and vitamin D3–treated groups (Fig. 2). In response
to insulin, the NE sensitivity of the vitamin D3-treated group
remained practically unchanged (Fig. 3). In the control and
DHT-treated groups, a 20% increase in contractility was ob-
served after rinsing and during the second compared with
theﬁrst NE-contraction (Fig. 3). No differenceswere found be-
tween the ﬁrst and second NE-contractions in the vitamin D3–
treated group, which suggests that vitamin D3 treatment im-
proves NE sensitivity. However, the most prominent insulin-
dependent relaxation was detected in the vitamin D3–treated
group (Fig. 2B). Comparing the insulin-dependent relaxation
to Ach-relaxation, highly signiﬁcant differences were noted.
Ach caused stronger relaxation in the control group than in
the two treated groups. Moreover, this difference remained
the same or increased during L-NAME blockade. These results
suggest that the relaxing effect of insulin is independent from
NO in the gracilis arterioles and that vitamin D3 restores
normal vascular tone independently from the NO system.
NO-mediated relaxation of insulin in humanmuscle arterioles
(30, 31) and Naþ-Kþ adenosine triphosphatase may play
independent roles in human vessel relaxation (32, 33). Luis
et al. have presented an NO-independent insulin-mediated di-
rect mechanism of relaxation on renal efferent arterioles in5
ORIGINAL ARTICLE: REPRODUCTIVE BIOLOGYrabbits (34). Physical exercise has been found to increase the
blood ﬂow stimulated by insulin in skin arterioles by acti-
vating K(Ca2þ) channels (35). Our results demonstrate that
DHT treatment probably partially decreases NO-mediated re-
laxation. During DHT treatment, a difference was noted in
Ach-relaxation. By blocking the NO pathway, minor con-
tractions were detected, suggesting the local involvement
of the prostanoid system (11, 36) and muscarinic Ach
receptors (37) in addition to the NO pathway. It has been
shown that insulin-dependent relaxation of the large vessels
(aorta) and gracilis arterioles are predominantly mediated by
NO and endothelium-derived hyperpolarizing factor/potas-
sium channels, respectively (38).
Wong et al.’s results demonstrate that vitamin D3 has a di-
rect vascular effect: lowering prostanoid-dependent vasocon-
striction in spontaneously hypertensive rats (SHRs) to the
level of Wistar-Kyoto rats (11). Therefore, a role for vitamin
D3 deﬁciency has been suggested in the pathomechanism of
hypertension, because vitamin D3 treatment also decreases
endothelial dysfunction in SHRs (11). Many authors have
suggested that a low serum level of vitamin D3 plays a role
in the insulin resistance observed in PCOS, which may be
corrected by vitamin D3 replacement (39). In type 2 diabetes,
vitamin D3 improved the ﬂow-mediated vasodilation of the
brachial artery (9). The latter study demonstrated the direct
vascular effects of vitamin D3 treatment: the ﬂow-mediated
dilation of the brachial artery was signiﬁcantly diminished
in patients with low serum levels of vitamin D3. Under exper-
imental conditions, a 6-week vitamin D3 treatment normal-
ized Ach-relaxation in SHRs. However, this effect was not
related to intracellular calcium balance, which remained
unchanged during the whole treatment; instead, it correlated
with decreases in reactive oxygen free radicals and
cyclooxygenase-1 expression (11). In light of the above,
when interpreting the effects of vitamin D3 under hyperan-
drogenic circumstances, one must consider the direct vascular
effect of vitamin D3 and DHT interactions as well as the
indirect vascular effects caused by improving insulin resis-
tance. The stability of the NE-induced contractions in vitamin
D3-treated rats demonstrates the role of vitamin D3 in pre-
serving vascular reactivity. According to studies performed
on rat aorta, vitamin D3 plays a role in maintaining vascular
reactivity and the vascular effects of sex hormones via crea-
tine kinase activity (40). Increased vascular endothelial
growth factor expression may also take part in the chronic
vasoprotective effects of vitamin D3 (41).CONCLUSIONS
This is the ﬁrst study investigating the vascular adaptation
and insulin sensitivity of gracilis arterioles in a PCOS model.
Our results show a partial NO dependency of vascular reactiv-
ity changes caused by hyperandrogenism. In our experimen-
tal model, vitamin D3 restored the systemic insulin response
as well as the NO-independent insulin-induced relaxation
and NE sensitivity of the gracilis arterioles. This is the ﬁrst
study demonstrating vascular insulin resistance of the gracilis
arterioles and the counteracting effect of vitamin D3 in an
experimental PCOS model.6Acknowledgments: The authors express their gratitude to
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